CHEMIMYCIN

This brand name is authorized in Nigeria.

Active ingredients

The drug CHEMIMYCIN contains one active pharmaceutical ingredient (API):

1	Clindamycin UNII T20OQ1YN1W - CLINDAMYCIN HYDROCHLORIDE
	Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.
	Read more about Clindamycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0434	Capsule	CHEMIMYCIN-150 CAPSULES CAP 150 mg 10 X 10	CHEMIMYCIN-150 CAPSULES CHEMIMYCIN CLINDAMYCIN HYDROCHLORIDE BP EQ. TO CLINDAMYCIN 150MG POM CAPSULES 10 X 10 ANTIBIOTIC CHEZ RESOURCES PHARM LTD 7, CALABAR STREET FEGGE, ONITSHA ANAMBRA STATE ALPA LABORATORIES PVT LTD 32/2 A. B ROAD PIGDAMBER-453446, INDORE (M.P), INDIA GMP- RBC LR- SATIS; FEES- PAID; NP: NA 02/10/2018 R R R C4-0434	30/01/2020
C4-0436	Capsule	CHEMIMYCIN-300 CAPSULES CAP 300 mg 10 X 10	CHEMIMYCIN-300 CAPSULES CHEMIMYCIN CLINDAMYCIN HYDROCHLORIDE BP EQ. TO CLINDAMYCIN 150MG POM CAPSULES 10 X 10 ANTIBIOTIC CHEZ RESOURCES PHARM LTD 7, CALABAR STREET FEGGE, ONITSHA ANAMBRA STATE ALPA LABORATORIES PVT LTD 32/2 A. B ROAD PIGDAMBER-453446, INDORE (M.P), INDIA GMP- RBC LR- SATIS; FEES- PAID; NP: NA 02/10/2018 R R R C4-0436	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FF01	Clindamycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0434, C4-0436